Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Hematologic Oncology|May 9, 2020
Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin's lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: a single-center real-life experienceVittorio R Zilioli, Cristina Muzi, Periana Minga, et al.
Bone Marrow Transplantation|April 30, 2020
Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter studyNicola Di Renzo, Maurizio Musso, Rosanna Scimè, et al.
Nature Communications|December 13, 2017
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancerBarbara Oldrini, Wan-Ying Hsieh, Hediye Erdjument-Bromage, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2021
Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantationNicola Di Renzo, Maurizio Musso, Rosanna Scimè, et al.
Blood|December 21, 2018
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphomaChristian Grommes, Sarah S Tang, Julia Wolfe, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of GliomaZenon Konteatis, Erin Artin, Brandon Nicolay, et al.
Cancer Discovery|June 17, 2017
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS LymphomaChristian Grommes, Alessandro Pastore, Nicolaos Palaskas, et al.
Pageof 2